📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Validation of the protein kinase Pf CLK3 as a multistage cross-species malarial drug target (2019)

First Author: Alam M

Attributed to: Bitopic protein kinase inhibition - a new paradigm in drug discovery funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/science.aau1682

PubMed Identifier: 31467193

Publication URI: http://europepmc.org/abstract/MED/31467193

Type: Journal Article/Review

Parent Publication: Science

Issue: 6456

ISSN: 0036-8075